Celecoxib Benefit Seen in ctDNA-Positive Colon Cancer

by | Dec 4, 2025 | Health

Spread the love
Researchers compared survival outcomes in patients with stage III colon cancer randomized to receive either celecoxib or placebo for 3 years with chemo.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments